share_log

Bruush Oral Care | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Yaletown Bros. Ventures Ltd.(2.8%),Matthew Friesen(2.8%), etc.

Bruush Oral Care | SC 13D/A:超過5%持股股東披露文件(修正)-Yaletown Bros. Ventures Ltd.(2.8%),Matthew Friesen(2.8%)等

SEC announcement ·  02/24 11:23
牛牛AI助理已提取核心訊息
On February 23, 2024, Yaletown Bros. Ventures Ltd, along with individuals Matthew Friesen and Bradley Friesen, filed an Amendment No. 4 to Schedule 13D with the SEC, indicating changes in their ownership of Bruush Oral Care Inc. common shares. The group, which had previously reported ownership stakes ranging from 63% to 82%, now holds approximately 2.8% of the company's common shares, amounting to 2,810,602 shares. This change follows a series of open market transactions between February 16 and February 22, 2024, where the Reporting Persons sold a total of 2,919,500 shares. The transactions included the sale of shares at prices ranging from $0.0575 to $0.0825. The Friesens, through Yaletown Bros. Ventures Ltd, have ceased to be the beneficial owner of more than five percent of Bruush Oral Care's common shares. This filing represents the final amendment to the Schedule 13D for the Reporting Persons, signaling a significant reduction in their investment in the company.
On February 23, 2024, Yaletown Bros. Ventures Ltd, along with individuals Matthew Friesen and Bradley Friesen, filed an Amendment No. 4 to Schedule 13D with the SEC, indicating changes in their ownership of Bruush Oral Care Inc. common shares. The group, which had previously reported ownership stakes ranging from 63% to 82%, now holds approximately 2.8% of the company's common shares, amounting to 2,810,602 shares. This change follows a series of open market transactions between February 16 and February 22, 2024, where the Reporting Persons sold a total of 2,919,500 shares. The transactions included the sale of shares at prices ranging from $0.0575 to $0.0825. The Friesens, through Yaletown Bros. Ventures Ltd, have ceased to be the beneficial owner of more than five percent of Bruush Oral Care's common shares. This filing represents the final amendment to the Schedule 13D for the Reporting Persons, signaling a significant reduction in their investment in the company.
2024年2月23日,耶魯敦兄弟風險投資有限公司以及個人馬修·弗裏森和布拉德利·弗裏森向美國證券交易委員會提交了附表13D第4號修正案,表明他們對Bruush Oral Care Inc.普通股的所有權發生了變化。該集團此前曾報告的所有權從63%到82%不等,現在持有該公司約2.8%的普通股,共計2,810,602股。這一變化是在2024年2月16日至2月22日期間進行的一系列公開市場交易之後發生的,申報人共出售了2919,500股股票。這些交易包括以0.0575美元至0.0825美元的價格出售股票。通過耶魯敦兄弟風險投資有限公司,弗裏森夫婦已不再是Bruush Oral Care超過5%的普通股的受益所有人。該文件是申報人附表13D的最終修訂,表明申報人對該公司的投資大幅減少。
2024年2月23日,耶魯敦兄弟風險投資有限公司以及個人馬修·弗裏森和布拉德利·弗裏森向美國證券交易委員會提交了附表13D第4號修正案,表明他們對Bruush Oral Care Inc.普通股的所有權發生了變化。該集團此前曾報告的所有權從63%到82%不等,現在持有該公司約2.8%的普通股,共計2,810,602股。這一變化是在2024年2月16日至2月22日期間進行的一系列公開市場交易之後發生的,申報人共出售了2919,500股股票。這些交易包括以0.0575美元至0.0825美元的價格出售股票。通過耶魯敦兄弟風險投資有限公司,弗裏森夫婦已不再是Bruush Oral Care超過5%的普通股的受益所有人。該文件是申報人附表13D的最終修訂,表明申報人對該公司的投資大幅減少。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。